Uncategorized

Former alcohol executive, Lee Applbaum of Bacardi, recently joined as executives at Surterra Wellness.

Former alcohol executive, Ed Brown of Patron Spirits International, recently joined as executives at Surterra Wellness.

Former Purdue Pharmaceuticals CEO, John Stewart, recently decided to take up marijuana. He founded Emblem, a Canadian medical marijuana company, shortly after leaving Purdue.

PAX Labs, founded by Adam Bowen and James Monsees, spun off Juul Labs from their vaporizer brand. The spun-off Juul boasted a product with the capacity of 200 puffs a day, equivalent to a pack of cigarettes, and pioneered a patent in nicotine salts. The ensuing teen vaping addiction epidemic has been owed to Juul’s innovative technology and aggressive youth marketing.

Altria Group, maker of Marlboro, invested $1.8B in Cronos for a 45% stake in the Canadian-based marijuana company.

Imperial Brands invested in an undisclosed stake in UK-based marijuana company, Oxford Cannabinoid Technologies.

Imperial Brands invested around $94.5M into Canadian marijuana company, Auxly, for a 20% stake in the company. The deal will allow the two companies to develop, produce, and sell vapor products and brands.

Canadian tobacco maker, Alliance One International, purchased a 40% stake in Critically, a North Carolina based CBD-hemp company for an estimated $10M. Alliance One is entitled to extend the investment to 50% in March of 2020.

Alliance One International subsidiary, FIGR Cannabis, acquired a 75% stake in Canada’s Island Garden, a Canadian medical marijuana company licensed in Prince Edward Island.

Alliance One International subsidiary, FIGR Cannabis, acquired an 80% stake in GoldLeaf Pharm Inc., licensed in the province of Ontario. The dollar amount is undisclosed.

Philip Morris International, one of the largest tobacco companies in the globe, invested $20M into Syqe Medical, an Israeli marijuana company that has created a marijuana inhaler.

Sandoz AG, a subsidiary of Novartis, agreed to a partnership with Tilray to co-brand and distribute non-smokable and non-combustible marijuana products. Financials were not disclosed.

Molson Coors elected to partner with HEXO (Hydropothecary Corporation) to develop marijuana-infused beverages. Molson Coors is entitled to purchase shares of HEXO through the deal.

Teva Pharmaceuticals agreed to a partnership with Australian marijuana company, CannaDoc. Through the deal, Teva Pharmaceuticals will distribute CannaDoc’s medical marijuana through pharmacies in Israel.

Teva Pharmaceuticals agreed to a marketing partnership with Syqe Medical, making the pharmaceutical company the sole distributor of Syqe’s proprietary marijuana inhaler. The value of the partnership was not disclosed.

Heineken subsidiary, Lagunitas, partnered with CannaCraft brand Absolute Xtracts to create a non-alcoholic marijuana infused beer. The initial hope was to create a hop-derived terpene for Absolute Xtract’s vape cartridges, which turned into a beer with marijuana terpenes. The idea was rejected by the federal Alcohol and Tobacco Tax and Trade Bureau.

Constellation Brands upped an initial investment in Canopy Growth from a 9.9% stake to a 38% stake valued at an additional $4B; the beer maker will be eligible to purchase 139.7 million more shares for $5B.

Anheuser-Busch invests $50M; partners with Tilray through subsidiary brand Labatt to create a marijuana infused drink.